May 2025 - Page 3 of 7 - NetworkNewsWire

ThursdayMay 22, 2025 9:45 am

FAVO Capital Inc. (FAVO): Filling the Financing Gap for Underserved SMBs

FAVO Capital is developing a digital lending platform tailored to small and medium-sized businesses, targeting gaps left by traditional banks Proprietary fintech tools and flexible financing solutions aim to provide capital access for businesses that are often denied by legacy lenders Rising demand for alternative credit sources presents a major opportunity for agile, tech-driven lenders like FAVO With over 5.5 million new business applications filed in the U.S. last year alone, small- to medium-sized businesses (“SMBs”) are thriving, but many are finding themselves underserved by traditional financial institutions. According to recent industry insights, 6 in 10 SMBs are denied access…

ThursdayMay 22, 2025 9:00 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Is ‘One to Watch’

The Santa Fe Mine hosts 1.95 million ounces of pit-constrained gold equivalent resources across Indicated and Inferred categories. A 2025 Preliminary Economic Assessment for Santa Fe outlines an after-tax NPV5% of $200 million and a 34.2% IRR based on spot pricing. All four projects are 100%-owned or under low-cost acquisition agreements, with development centered in Nevada, the world’s top mining jurisdiction. Near-term catalysts include Santa Fe permitting milestones, West Santa Fe’s maiden drill program, and an updated economic study. The company is led by a proven team with multiple M&A exits and extensive experience in advancing heap-leach gold operations. Lahontan…

WednesdayMay 21, 2025 10:30 am

ONAR Holding Corp. (ONAR): Building a Martech Powerhouse Through AI and Strategic Acquisitions

ONAR's acquisition-led growth operation is accelerating, with a major marketing tech acquisition set to double revenues at subsidiary Storia AI, data, and automation are at the core of ONAR’s efforts to help middle-market clients achieve measurable marketing performance Fiscal 2024 marked major operational progress, with asset growth, cost reduction, and increasing investor confidence through successful capital raises Marketing in the Age of AI and Data Marketing is undergoing a once-in-a-generation transformation, powered by artificial intelligence, real-time data, and next-generation automation. Today’s marketing systems aren’t static; they’re dynamic, adaptive, and personalized in real time. For growth-stage and middle-market businesses, this shift…

WednesdayMay 21, 2025 9:45 am

Brera Holdings PLC (NASDAQ: BREA) Eyes Expansion as Sports Investing Gains Institutional Momentum

Sports investing is emerging as a recognized alternative asset class, attracting institutional capital. Media rights, digital expansion, and global fan engagement are driving up sports asset valuations, with the sector expected to surpass $700 billion in value by 2030. Brera focuses on sustainable football investment in growth-stage clubs rather than high-profile acquisitions; the company’s 2023 Nasdaq IPO was the first-ever listing of a multi-club ownership (“MCO”) group. A pending $2 billion IPO from Eagle Football Holdings could bring more visibility to the MCO model. As sports investing gains traction among institutional investors, Brera Holdings (NASDAQ: BREA), a global sports investment…

WednesdayMay 21, 2025 9:00 am

Adageis Offers Easy-to-Use AI-Driven Solution to Help Healthcare Providers Unlock High-Value Care, Maximize Revenue

Adageis delivers a user-friendly platform that helps providers identify high-value services while improving care quality. The company’s patented ProActive Care Platform leverages AI to shift providers from fee-for-service to value-based care models. The system integrates seamlessly with major EHR platforms to enhance operations without disrupting workflows. Adageis supports over 260,000 patient lives and expects that figure to more than double by the end of Q2 2025. The company is helping providers better understand insurance contract value and advocate for appropriate reimbursement. For healthcare practices navigating the shift toward value-based care, the complexity of insurance contracts, quality metrics, and data reporting…

TuesdayMay 20, 2025 12:35 pm

FAVO Capital Inc. (FAVO) Delivering Funding Solutions in Private Credit Market, Poised for Significant Growth

Momentum suggests a positive trajectory in the private credit market in the coming year. FAVO Capital offers flexible capital solutions tailored to SMBs’ unique needs. The company’s approach exemplifies how private credit firms are leveraging technology to enhance their offerings. The private credit market is on the cusp of substantial expansion in 2025, driven by a resurgence in global mergers and acquisitions (“M&A”), the digitization of lending processes and the emergence of innovative financing solutions tailored for small and medium-sized businesses (“SMBs”) (https://nnw.fm/mXPzg). This confluence of factors is reshaping the financial landscape, as companies such as FAVO Capital (OTC: FAVO)…

TuesdayMay 20, 2025 11:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) CEO Discusses Business Model, Competitive Advantage During GotStocks Podcast

CEO Dr. Richard Lu discussed SolarBank’s vertically integrated business model on a recent GotStocks podcast. SolarBank is an expanding developer, builder, operator, and owner of clean energy projects across North America, maintaining a $184 million portfolio of assets generating recurring revenue. The company’s flexible supply chain strategy helps mitigate any tariff risks while reducing costs. Going forward, a recently announced up to $100 million transaction with CIM Group is set to fund up to 97 MW of U.S. community solar projects. Disseminated on behalf of SolarBank Corporation Dr. Richard Lu, CEO of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2),…

TuesdayMay 20, 2025 10:00 am

Siyata Mobile Inc. (NASDAQ: SYTA) Is ‘One to Watch’

Siyata Mobile is gaining traction across North America with its purpose-built push-to-talk (PTT) devices and Uniden(R)-branded cellular signal boosters. Its SD7 handset offers a rugged, LTE-based replacement for traditional two-way radios in public safety and industrial sectors. Signal boosters enhance connectivity in vehicles, buildings, and remote zones, supporting mission-critical communications. Distribution wins with major U.S. carriers and public sector agencies highlight growing demand and deployment momentum. The company’s carrier-integrated model aligns with rising needs for scalable, reliable communication infrastructure. Siyata Mobile Inc. (NASDAQ: SYTA) is a technology company providing advanced communication solutions for frontline workers, emergency responders, and mobile workforces.…

TuesdayMay 20, 2025 9:45 am

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout

Medical technology company Intelligent Bio Solutions has launched Arabic, Italian, and Spanish websites to support expansion into key international markets. The move opens digital access to over 1.4 billion people across Latin America, the Middle East, and Southern Europe. The rollout aligns with increased demand for non-invasive workplace drug testing and compliance tools. INBS’s flagship fingerprint sweat-based drug screening system is currently used by over 450 clients in 24 countries. The company plans a U.S. market launch in 2025 as it continues to develop additional biosensor applications. Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive…

TuesdayMay 20, 2025 9:00 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central nervous system disorders. The company’s lead candidate, NRX-100 (preservative free IV ketamine), NDA in process with the FDA, has been granted Fast Track designation by the FDA for acute suicidal depression, and a patent for this novel formulation has been filed with the U.S. Patent and Trademark Office. NRX-101 (oral D-cycloserine/lurasidone), has received FDA Breakthrough Therapy designation, expediting its development. HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in forward looking revenue by year-end 2025, through development of a national clinic network treating suicidal depression,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: May 2025